Tredje Ap Fonden Vertex Pharmaceuticals Inc Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

A detailed history of Tredje Ap Fonden transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tredje Ap Fonden holds 129,474 shares of VRTX stock, worth $58.4 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

129,474

Previous 91,601 41.35%

Holding current value

$58.4 Million

Previous $42.9 Million 40.25%

% of portfolio

0.56%

Previous 0.42%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$460.0 - $505.78 $17.4 Million - $19.2 Million	37,873 Added 41.35%	129,474 $60.2 Million
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $4.95 Million - $6.12 Million	-12,614 Reduced 12.1%	91,601 $42.9 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $15.1 Million - $16.5 Million	37,000 Added 55.05%	104,215 $43.6 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $826,630 - $989,738	2,410 Added 3.72%	67,215 $27.3 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $92,661 - $99,314	274 Added 0.42%	64,805 $22.5 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $213,176 - $238,594	678 Added 1.06%	64,531 $22.7 Million
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $505,848 - $577,056	1,786 Added 2.88%	63,853 $20.1 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $1.26 Million - $1.42 Million	4,418 Added 7.66%	62,067 $17.9 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $7.94 Million - $8.86 Million	28,983 Added 101.11%	57,649 $16.7 Million
Q2 2020 Aug 11, 2020	SELL	$225.48 - $295.8 $7.2 Million - $9.45 Million	-31,934 Reduced 52.7%	28,666 $8.32 Million
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $696,198 - $863,617	3,485 Added 6.1%	60,600 $14.8 Million
Q4 2019 Feb 10, 2020	SELL	$166.71 - $223.91 $305,412 - $410,203	-1,832 Reduced 3.11%	57,115 $12.5 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $32,581 - $36,669	196 Added 0.33%	58,947 $9.99 Million
Q2 2019 Aug 09, 2019	SELL	$164.61 - $190.37 $16,296 - $18,846	-99 Reduced 0.17%	58,751 $10.8 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $386,402 - $459,492	2,360 Added 4.18%	58,850 $10.8 Million
Q4 2018 Feb 11, 2019	SELL	$151.91 - $192.21 $5.59 Million - $7.08 Million	-36,820 Reduced 39.46%	56,490 $9.36 Million
Q2 2018 Aug 09, 2018	SELL	$145.72 - $169.96 $2.76 Million - $3.22 Million	-18,957 Reduced 16.89%	93,310 $15.9 Million
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $65,188 - $76,165	430 Added 0.38%	112,267 $18.3 Million
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $529,900 - $600,423	3,860 Added 3.57%	111,837 $16.8 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $16 Million - $17.5 Million	107,977	107,977 $16.4 Million

Others Institutions Holding VRTX

# of Institutions

1,721

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account